- Business Wire•4 days ago
Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that Hagop Youssoufian, MSc, MD, has been appointed Head of Hematology and Oncology Development.
- Benzinga•4 days ago
Verastem Inc (NASDAQ: VSTM ) is a biopharmaceutical company that focuses on discovering and developing therapies for the treatment of patients with cancer. Verastem acquired a license agreement from Infinity ...
- GlobeNewswire•15 days ago
--Appoints Four New, Highly Qualified Independent Directors: Jason Aryeh, Dr. Geoffrey Cox, Robert Forrester and Bob Oliver--–. --Announces Chairman and CEO Succession Plans--–.
VSTM : Summary for Verastem, Inc. - Yahoo Finance
Verastem, Inc. (VSTM)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.17 x 300|
|Ask||1.49 x 1000|
|Day's Range||1.12 - 1.17|
|52 Week Range||1.05 - 1.93|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.16|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|